Shopping Cart 0
Cart Subtotal
USD 0

Global E-Clinical solutions Market: Market Segments: By Product Type (CTMS, eCOA, Analytics, RTMS, eTMF, Safety, CDMS, EDC); By Delivery Mode (On-Demand, On-premise, Cloud-based; ByEnd-User (CROs, Hospitals, Pharma/Biopharma Companies); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option : NO
Copy Option : No
Download Option: No
Deliverable Format : Excel viewable on the website via username

Excel Only
USD 2800

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3850

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 0

Details

Product Overview
E-Clinical solutions combine clinical technology and experience and are used through data processing and data analysis to facilitate the clinical development process. In addition to the increasing number of CROs and life sciences organizations, the growing trend of outsourcing clinical trials to contract research organizations (CROs) is poised to help the industry gain considerable momentum in the coming years. Factors such as increasing the number of clinical trials, increasing the implementation of technological solutions during clinical trials, increasing the need for better data standardization, increasing the need for data processing and monitoring and research intensification, and expenditure on growth by pharmaceutical and biotechnology companies are driving the market. The growth of the industry is further fueled by the expansion of clinical trial outsourcing, the extension of government grants to fund clinical research, and the amplification of IT budgets for drug production.
Market Highlights
Global E-Clinical Solutions Market is expected to project a notable CAGR of XX.X% in 2030.
Global E-Clinical Solutions Market to surpass USD XXXX million by 2030 from USD XXXX million in 2018 at a CAGR of XX% throughout the forecast period, i.e. 2019-30. Major factors characterizing the market growth are increasing R&D activities by biopharmaceutical and pharmaceutical companies, growing expenditure on the production of clinical trials, the burden of chronic diseases, and increased adoption of smart devices for healthcare management.
                                 
Global E-Clinical Solutions Market: Segments
Web-based delivery mode segment to grow with the highest CAGR of XX.X% during 2019-30
Global E-Clinical Solutions Market is segmented by delivery mode into web-hosted (on-demand), licensed enterprise (on-premise), and cloud-based solutions. The largest share in 2019 was in the Web-hosted (on-demand) segment. Multiple factors are responsible for their large market shares, such as easy user access, cost reductions, and faster data retrieval. During the forecast period, the cloud-based distribution mode segment is expected to report the highest growth rate. With a fixed monthly fee provided by cloud-based models, the ease of integration, faster implementation, and flexible scalability are expected to drive the market for these solutions.
The pharmaceutical and biopharmaceutical segment to grow with the highest CAGR of XX.X% during 2019-30
Global E-Clinical Solutions Market is segmented by end-users into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical. device manufacturers, hospitals, and academic research institutions.  The multiple usages of E-Clinical solutions enhance the performance of clinical trials and decrease the total expense and time involved in the production of drugs. These advantages have resulted in a rise in pharmaceutical and biopharmaceutical companies' adoption of automated technology for medicines.
Global E-Clinical Solutions Market: Market Dynamics
Drivers
Increase in clinical trials
Factors such as increasing the number of clinical trials, increasing the implementation of technological solutions during clinical trials, increasing the need for better data standardization, increasing the need for data processing and monitoring and research intensification, and expenditure on growth by pharmaceutical and biotechnology companies are driving the market. The growth of the industry is further fueled by the expansion of clinical trial outsourcing, the extension of government grants to fund clinical research, and the amplification of IT budgets for drug production.
Stringent regulatory structure
In developed economies such as the United States, the existence of a strict regulatory framework for clinical trials and an increased need for safety monitoring also plays a vital role in the adoption of E-Clinical solutions in addition to this, during the review period, rising government grants for substantiated trials and growing the end-user base for E-Clinical solutions are likely to fuel the market.
Restraints
High operational costs associated with cleanrooms
High implementation costs coupled with the lack of trained professionals can pose a major obstacle to the growth of the market for E-Clinical solutions. It is also assumed that the materials used for the development of these technologies would have unique characteristics. The high cost-related installation and usage of cleanrooms are, however, expected to impede market growth during the forecast period.
Global E-Clinical Solutions Market: Regions
Global E-Clinical Solutions Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.
Global E-Clinical Solutions Market in North America held the largest market share of XX.X% in the year 2019. The growing target population, coupled with the prevalence of lifestyle-related diseases such as diabetes and heart disease, is poised to stimulate the growth of E-Clinical solutions in the regional market. Also, the position of major players and the availability of advanced infrastructure is expected to accentuate the growth of the regional market.
                    
Global E-Clinical Solutions Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Global E-Clinical Solutions Market: Key Players
  • Oracle Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Medidata Solutions, In
  • Parexel International Corporation
  • Bioclinica, Inc. (A Subsidiary of Cinven)
  • Datatrak International, Inc.
  • CRF Health
  • ERT Clinical
  • Merge Healthcare Incorporated
  • Omnicomm Systems, Inc.
  • Maxisit Inc.
  • Bio-Optronics, Inc.
  • E-Clinical Solutions, LLC.
Global E-Clinical Solutions Market report also contains analysis on:
Global E-Clinical Solutions Market Segments:
  • By Product Type

    • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
    • Clinical Trial Management Systems (CTMS)
    • Clinical Analytics Platform
    • Randomization and Trial Supply Management (RTMS)
    • Clinical Data Integration Platform
    • Electronic Clinical Outcome Assessment (eCOA)
    • Safety Solutions
    • Electronic Trail Master Files (eTMF)
    • Regulatory Information Management Solutions (RIMS)
    • Others
    • By Delivery Mode
      • Web-hosted
      • Licensed Enterprise
      • Cloud-based
    • By End-User
      • Pharmaceutical and Biopharmaceutical Companies
      • Contract Research Organizations
      • Consulting Service Companies
      • Medical Device Manufacturers
      • Hospitals
      • Academic Research Institutions 
  • E-Clinical Solutions Market Dynamics
  • E-Clinical Solutions Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints
READ MORE

Table Of Content

Scope

Contents          

  1. Executive Summary
  2. Global E-Clinical Solutions Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global E-Clinical Solutions Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global E-Clinical Solutions Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12. Global E-Clinical Solutions Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. By Product Type: Market Share (2020-2030F)
      1. EDC & CDMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. CTMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Clinical Analytics Platform, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. RTMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Clinical Data Integration Platform, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      6. eCOA, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      7. Safety Solutions, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      8. eTMF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      9. RIMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      10. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.3. By Delivery Mode: Market Share (2020-2030F)

12.3.1.          Web-hosted, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.3.2.         Licensed Enterprise, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.3.3.          Softwall cleanrooms, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.3.4.          Cloud-based, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4. By End-Users: Market Share (2020-2030F)

12.4.1.          Pharmaceutical and Biopharmaceutical Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 202-2030F

12.4.2.          Contract Research Organizations, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4.3.         Consulting Service Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4.4.         Medical Device Manufacturers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4.5.         Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4.4.         Academic Research Institutions, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

  1. Company Profile
    1. Oracle Corporation
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. Medidata Solutions, Inc.
    3. Parexel International Corporation
    4. Bioclinica, Inc.
    5. Datatrak International, Inc.
    6. CRF Health
    7. ERT Clinical
    8. Merge Healthcare Incorporated
    9. Omnicomm Systems, Inc.
    10. Other Prominent Players
  2. Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Licence Rights

  • Single User License:

    Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization. The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete/part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

  •  
  • Hard Copy License:

    The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

  •  
  • Corporate User License:

    Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Product Overview
E-Clinical solutions combine clinical technology and experience and are used through data processing and data analysis to facilitate the clinical development process. In addition to the increasing number of CROs and life sciences organizations, the growing trend of outsourcing clinical trials to contract research organizations (CROs) is poised to help the industry gain considerable momentum in the coming years. Factors such as increasing the number of clinical trials, increasing the implementation of technological solutions during clinical trials, increasing the need for better data standardization, increasing the need for data processing and monitoring and research intensification, and expenditure on growth by pharmaceutical and biotechnology companies are driving the market. The growth of the industry is further fueled by the expansion of clinical trial outsourcing, the extension of government grants to fund clinical research, and the amplification of IT budgets for drug production.
Market Highlights
Global E-Clinical Solutions Market is expected to project a notable CAGR of XX.X% in 2030.
Global E-Clinical Solutions Market to surpass USD XXXX million by 2030 from USD XXXX million in 2018 at a CAGR of XX% throughout the forecast period, i.e. 2019-30. Major factors characterizing the market growth are increasing R&D activities by biopharmaceutical and pharmaceutical companies, growing expenditure on the production of clinical trials, the burden of chronic diseases, and increased adoption of smart devices for healthcare management.
                                 
Global E-Clinical Solutions Market: Segments
Web-based delivery mode segment to grow with the highest CAGR of XX.X% during 2019-30
Global E-Clinical Solutions Market is segmented by delivery mode into web-hosted (on-demand), licensed enterprise (on-premise), and cloud-based solutions. The largest share in 2019 was in the Web-hosted (on-demand) segment. Multiple factors are responsible for their large market shares, such as easy user access, cost reductions, and faster data retrieval. During the forecast period, the cloud-based distribution mode segment is expected to report the highest growth rate. With a fixed monthly fee provided by cloud-based models, the ease of integration, faster implementation, and flexible scalability are expected to drive the market for these solutions.
The pharmaceutical and biopharmaceutical segment to grow with the highest CAGR of XX.X% during 2019-30
Global E-Clinical Solutions Market is segmented by end-users into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical. device manufacturers, hospitals, and academic research institutions.  The multiple usages of E-Clinical solutions enhance the performance of clinical trials and decrease the total expense and time involved in the production of drugs. These advantages have resulted in a rise in pharmaceutical and biopharmaceutical companies' adoption of automated technology for medicines.
Global E-Clinical Solutions Market: Market Dynamics
Drivers
Increase in clinical trials
Factors such as increasing the number of clinical trials, increasing the implementation of technological solutions during clinical trials, increasing the need for better data standardization, increasing the need for data processing and monitoring and research intensification, and expenditure on growth by pharmaceutical and biotechnology companies are driving the market. The growth of the industry is further fueled by the expansion of clinical trial outsourcing, the extension of government grants to fund clinical research, and the amplification of IT budgets for drug production.
Stringent regulatory structure
In developed economies such as the United States, the existence of a strict regulatory framework for clinical trials and an increased need for safety monitoring also plays a vital role in the adoption of E-Clinical solutions in addition to this, during the review period, rising government grants for substantiated trials and growing the end-user base for E-Clinical solutions are likely to fuel the market.
Restraints
High operational costs associated with cleanrooms
High implementation costs coupled with the lack of trained professionals can pose a major obstacle to the growth of the market for E-Clinical solutions. It is also assumed that the materials used for the development of these technologies would have unique characteristics. The high cost-related installation and usage of cleanrooms are, however, expected to impede market growth during the forecast period.
Global E-Clinical Solutions Market: Regions
Global E-Clinical Solutions Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.
Global E-Clinical Solutions Market in North America held the largest market share of XX.X% in the year 2019. The growing target population, coupled with the prevalence of lifestyle-related diseases such as diabetes and heart disease, is poised to stimulate the growth of E-Clinical solutions in the regional market. Also, the position of major players and the availability of advanced infrastructure is expected to accentuate the growth of the regional market.
                    
Global E-Clinical Solutions Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Global E-Clinical Solutions Market: Key Players
  • Oracle Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Medidata Solutions, In
  • Parexel International Corporation
  • Bioclinica, Inc. (A Subsidiary of Cinven)
  • Datatrak International, Inc.
  • CRF Health
  • ERT Clinical
  • Merge Healthcare Incorporated
  • Omnicomm Systems, Inc.
  • Maxisit Inc.
  • Bio-Optronics, Inc.
  • E-Clinical Solutions, LLC.
Global E-Clinical Solutions Market report also contains analysis on:
Global E-Clinical Solutions Market Segments:
  • By Product Type

    • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
    • Clinical Trial Management Systems (CTMS)
    • Clinical Analytics Platform
    • Randomization and Trial Supply Management (RTMS)
    • Clinical Data Integration Platform
    • Electronic Clinical Outcome Assessment (eCOA)
    • Safety Solutions
    • Electronic Trail Master Files (eTMF)
    • Regulatory Information Management Solutions (RIMS)
    • Others
    • By Delivery Mode
      • Web-hosted
      • Licensed Enterprise
      • Cloud-based
    • By End-User
      • Pharmaceutical and Biopharmaceutical Companies
      • Contract Research Organizations
      • Consulting Service Companies
      • Medical Device Manufacturers
      • Hospitals
      • Academic Research Institutions 
  • E-Clinical Solutions Market Dynamics
  • E-Clinical Solutions Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints
READ MORE

Scope

Contents          

  1. Executive Summary
  2. Global E-Clinical Solutions Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global E-Clinical Solutions Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global E-Clinical Solutions Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12. Global E-Clinical Solutions Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. By Product Type: Market Share (2020-2030F)
      1. EDC & CDMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. CTMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Clinical Analytics Platform, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. RTMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Clinical Data Integration Platform, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      6. eCOA, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      7. Safety Solutions, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      8. eTMF, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      9. RIMS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      10. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.3. By Delivery Mode: Market Share (2020-2030F)

12.3.1.          Web-hosted, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.3.2.         Licensed Enterprise, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.3.3.          Softwall cleanrooms, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.3.4.          Cloud-based, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4. By End-Users: Market Share (2020-2030F)

12.4.1.          Pharmaceutical and Biopharmaceutical Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 202-2030F

12.4.2.          Contract Research Organizations, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4.3.         Consulting Service Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4.4.         Medical Device Manufacturers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4.5.         Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12.4.4.         Academic Research Institutions, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

  1. Company Profile
    1. Oracle Corporation
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. Medidata Solutions, Inc.
    3. Parexel International Corporation
    4. Bioclinica, Inc.
    5. Datatrak International, Inc.
    6. CRF Health
    7. ERT Clinical
    8. Merge Healthcare Incorporated
    9. Omnicomm Systems, Inc.
    10. Other Prominent Players
  2. Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

  • Single User License:

    Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization. The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete/part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

  •  
  • Hard Copy License:

    The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

  •  
  • Corporate User License:

    Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS